Works matching IS 14741776 AND DT 2010 AND VI 9 AND IP 3
Results: 23
Vaccines: New vaccine platform?
- Published in:
- Nature Reviews Drug Discovery, 2010, v. 9, n. 3, p. 191, doi. 10.1038/nrd3117
- By:
- Publication type:
- Article
Anticancer drugs: Actively targeting mTOR.
- Published in:
- Nature Reviews Drug Discovery, 2010, v. 9, n. 3, p. 193, doi. 10.1038/nrd3118
- By:
- Publication type:
- Article
Kinase inhibitors: A winning combination against BCR–ABL.
- Published in:
- Nature Reviews Drug Discovery, 2010, v. 9, n. 3, p. 194, doi. 10.1038/nrd3119
- By:
- Publication type:
- Article
Phenotypic screening: Zebrafish behaviour in profile.
- Published in:
- Nature Reviews Drug Discovery, 2010, v. 9, n. 3, p. 192, doi. 10.1038/nrd3120
- By:
- Publication type:
- Article
Type 1 diabetes.
- Published in:
- 2010
- By:
- Publication type:
- journal article
How to improve R&D productivity: the pharmaceutical industry's grand challenge.
- Published in:
- 2010
- By:
- Publication type:
- review
Membrane transporters in drug development.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Protein aggregation diseases: pathogenicity and therapeutic perspectives.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Challenges with advanced therapy medicinal products and how to meet them.
- Published in:
- 2010
- By:
- Publication type:
- review
Affective disorders: A faster way to happiness.
- Published in:
- Nature Reviews Drug Discovery, 2010, v. 9, n. 3, p. 192, doi. 10.1038/nrd3121
- By:
- Publication type:
- Article
News in brief.
- Published in:
- Nature Reviews Drug Discovery, 2010, v. 9, n. 3, p. 194, doi. 10.1038/nrd3122
- Publication type:
- Article
In this issue.
- Published in:
- Nature Reviews Drug Discovery, 2010, v. 9, n. 3, p. 173, doi. 10.1038/nrd3123
- Publication type:
- Article
Transporters in drug development: advancing on the Critical Path.
- Published in:
- Nature Reviews Drug Discovery, 2010, v. 9, n. 3, p. 175, doi. 10.1038/nrd3124
- By:
- Publication type:
- Article
Ecallantide.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Deal watch: Novartis licenses GenVec's hearing loss programme.
- Published in:
- 2010
- Publication type:
- journal article
Trial watch: SGLT2 inhibitor shows promise in type 2 diabetes.
- Published in:
- Nature Reviews Drug Discovery, 2010, v. 9, n. 3, p. 182, doi. 10.1038/nrd3127
- Publication type:
- Article
Deal watch: Trends in discovery externalization.
- Published in:
- Nature Reviews Drug Discovery, 2010, v. 9, n. 3, p. 183, doi. 10.1038/nrd3128
- By:
- Publication type:
- Article
Biologics target bad bugs.
- Published in:
- Nature Reviews Drug Discovery, 2010, v. 9, n. 3, p. 177, doi. 10.1038/nrd3129
- By:
- Publication type:
- Article
A Wellcome experiment in seeding drug discovery.
- Published in:
- 2010
- By:
- Publication type:
- journal article
RNA-based therapeutics.
- Published in:
- Nature Reviews Drug Discovery, 2010, v. 9, n. 3, p. 249, doi. 10.1038/nrd3131
- Publication type:
- Article
News in brief.
- Published in:
- Nature Reviews Drug Discovery, 2010, v. 9, n. 3, p. 181, doi. 10.1038/nrd3132
- Publication type:
- Article
Patent watch.
- Published in:
- 2010
- By:
- Publication type:
- journal article
David Eddy.
- Published in:
- 2010
- By:
- Publication type:
- Interview